November 1, 2023 Comments Off on New patent for Astrazeneca drug CALQUENCE Posted in: Patent Added Annual Drug Patent Expirations for CALQUENCE Calquence is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eight patents protecting…
The post New patent for Astrazeneca drug CALQUENCE appeared fir…
November 1, 2023 Comments Off on New patent for Mallinckrodt Ireland drug TERLIVAZ Posted in: Patent Added Annual Drug Patent Expirations for TERLIVAZ Terlivaz is a drug marketed by Mallinckrodt Ireland and is included in one NDA. It is available from one supplier. The generic ingredient in…
The post New patent for Mallinckrodt Ireland drug TERLIVAZ appeare…